UK FSA Admits It Could Have ‘Better Anticipated’ CBD Application Bottleneck
In a report to a forthcoming board meeting, UK FSA policy head Rebecca Sudworth acknowledges that the agency could have “better anticipated” the surge in cannabidiol applications received just before the 31 March 2021 deadline.
You may also be interested in...
When it comes to assessing the safety of CBD in foods, the EU appears to be lagging behind the UK. Food Standards Agency CEO Emily Miles has noted that EFSA recently reached the same conclusions as the UK’s Committee on Toxicity did two years ago: there are still evidence gaps relating to CBD as a food. This may reassure UK operators that with the FSA further along in the assessment process it will not follow EFSA in suspending CBD novel food applications - but as expert Greer Deal notes, it's too soon to say.
The UK Food Standards Agency has published its much anticipated searchable, online CBD public list. But after a long wait, the list's publication has triggered a wave of anxiety and criticism from CBD firms and experts.
France's Ministry of Solidarity and Health published a decree allowing the commercial sale of cannabis sativa extracts with a maximum THC content up to 0.3%, but banning the sale of raw cannabis flowers and leaves to consumers in all their forms, thus elimating a booming CBD market for tea, for example. The ban, however, has been halted by France's highest administrative court on the basis that it is disproportionate. While the Conseil d’Etat makes its final decision, French bricks-and-mortar and online CBD retailers can continue selling low-THC cannabis flowers and leaves.